CD2 identification in APL was strongly linked with high leukocytosis (P = 0.004), shorter time to relapse and high relapse rate (P = 0.03), and lower overall survival (P = 0.07) than in patients with APL with negative CD2 detection [24]. The gene discussed is CD2; the disease is acute promyelocytic leukemia.